scholarly journals CRISPR screening strategies for microRNA target identification

FEBS Journal ◽  
2020 ◽  
Vol 287 (14) ◽  
pp. 2914-2922 ◽  
Author(s):  
Bing Yang ◽  
Katherine McJunkin
2011 ◽  
Vol 286 ◽  
pp. 79-84 ◽  
Author(s):  
Wan J. Hsieh ◽  
Hsiuying Wang

2015 ◽  
pp. 135-166 ◽  
Author(s):  
Fatma Al-­Awadhi ◽  
Lilibeth Salvador ◽  
Hendrik Luesch

Biology ◽  
2013 ◽  
Vol 2 (1) ◽  
pp. 189-205 ◽  
Author(s):  
Aida Martinez-Sanchez ◽  
Chris Murphy

2011 ◽  
Vol 39 (16) ◽  
pp. 6845-6853 ◽  
Author(s):  
D. W. Thomson ◽  
C. P. Bracken ◽  
G. J. Goodall

2018 ◽  
Vol 4 (4) ◽  
pp. 31 ◽  
Author(s):  
Lauren Gay ◽  
Peter Turner ◽  
Rolf Renne

Numerous cellular processes are regulated by microRNAs (miRNAs), both cellular and viral. Elucidating the targets of miRNAs has become an active area of research. An important method in this field is cross-linking and immunoprecipitation (CLIP), where cultured cells or tissues are UV-irradiated to cross-link protein and nucleic acid, the RNA binding protein of interest is immunoprecipitated, and the RNAs pulled down with the protein are isolated, reverse-transcribed, and analyzed by sequencing. CLIP using antibody against Argonaute (Ago), which binds to both miRNA and mRNA as they interact in RISC, has allowed researchers to uncover a large number of miRNA targets. Coupled with high-throughput sequencing, CLIP has been useful for revealing miRNA targetomes for the γ-herpesviruses Kaposi’s sarcoma-associated herpesvirus (KSHV) and Epstein-Barr virus (EBV). Variants on the CLIP protocol are described, with the benefits and drawbacks of each. In particular, the most recent methods involving RNA–RNA ligation to join the miRNA and its RNA target have aided in target identification. Lastly, data supporting biologically meaningful interactions between miRNAs and long non-coding RNAs (lncRNAs) are reviewed. In summary, ribonomics-based miRNA targetome analysis has expanded our understanding of miRNA targeting and has provided a rich resource for EBV and KSHV research with respect to pathogenesis and tumorigenesis.


2014 ◽  
Vol 21 (8) ◽  
pp. 1249-1268 ◽  
Author(s):  
Thomas Bertero ◽  
Karine Robbe-Sermesant ◽  
Kevin Le Brigand ◽  
Gilles Ponzio ◽  
Nicolas Pottier ◽  
...  

2009 ◽  
Vol 5 (9) ◽  
pp. e1000516 ◽  
Author(s):  
Stephen A. Stanhope ◽  
Srikumar Sengupta ◽  
Johan den Boon ◽  
Paul Ahlquist ◽  
Michael A. Newton

2001 ◽  
Vol 6 (3) ◽  
pp. 133-136 ◽  
Author(s):  
Len Pagliaro ◽  
Morten Præstegaard

During 1999, Journal of Biomolecular Screening presented a series of Point-Counterpoint articles that addressed a question posed by editor Bill Janzen: "What is the future of HTS?" These articles discussed many of the global issues involved in HTS, such as target identification and library size, as well as the scientific and technical challenges facing the field. In this perspective we address a related, but very focused, issue that is increasingly important for many of us in the HTS community: the use of stably transfected cell lines as an integral part of screening strategies. Transfected cell lines provide powerful tools for assay design, but at the same time they introduce complex variables into the screening system. Although it is difficult to develop precise definitions and standards for biologicals such as cell lines, we propose that the development of guidelines for the nomenclature and use of transfected cell lines is essential for their use in HTS.


Sign in / Sign up

Export Citation Format

Share Document